Sharechat Logo

Infratil Limited (NZX: IFT) CDC Data Centres 31 December 2020 Valuation

Tuesday 5th January 2021

Text too small?

Infratil advises that an independent valuation of CDC Data Centres (“CDC”) as at 31 December 2020 indicates a significant increase in the value of Infratil’s investment in CDC since 30 September 2020. Infratil’s 48.1% investment in CDC is now valued at between A$2,039 million to A$2,334 million, up from A$1,597 million to A$1,807 million at 30 September 2020. Based on the NZD/AUD exchange rate on 31 December 2020, the NZD valuation of Infratil’s investment in CDC was $2,164.3 million to $2,478.7 million (with a midpoint of $2,313.5 million).

This valuation increase reflects the acceleration in demand that CDC is experiencing from new and existing customers across its portfolio, which is expected to result in its existing data centres reaching capacity earlier than expected, with a consequential effect on forecast growth. Infratil will provide a further update from CDC, including its growth plans, at Infratil’s Investor Day on 16 February 2021.

Impact on Estimated FY2021 International Portfolio Annual Incentive Fee

On 12 November 2020, as part of its interim results for the six months to 30 September 2020, Infratil provided an estimate of its FY2021 International Portfolio Incentive Fee accrual. Based on the 31 December 2020 independent valuation of CDC, Infratil advises that the estimated International Portfolio Annual Incentive Fee is now $147.6 million, an increase of $89.9 million since the 30 September 2020 accrual.

The assessment of the International Portfolio Annual Incentive Fee in relation to Tilt Renewables, Longroad Energy, RetireAustralia and Australian Social Infrastructure Partners has not been updated since the 30 September 2020 estimate. As at 30 September 2020, the value of Infratil’s shareholding in Tilt Renewables was the equivalent of $3.70 per Tilt Renewables share. On 7 December 2020, Infratil announced that it is undertaking a strategic review of its investment in Tilt Renewables, which it expects to conclude within six months. As the strategic review process is ongoing an updated assessment of the value of Infratil’s shareholding was not undertaken, however we note that the price per Tilt Renewables share on the NZX as at 31 December 2020 was $6.37. Infratil will continue to update the market of any material developments in relation to the strategic review.

Infratil notes that the actual International Portfolio Annual Incentive Fee as at 31 March 2021 will be determined based on independent valuations of each of the relevant investments. If an International Portfolio Annual Incentive Fee is ultimately determined to be payable at 31 March 2021, the fee will be payable in three equal tranches over the period to 31 March 2023, with the payment of the latter two tranches only being payable if the total valuation of the relevant investments as at 31 March 2022 and 31 March 2023 respectively, is no less than the total valuations determined as at 31 March 2021.

See the links below for more details:

CDC Data Centres 31 December 2020 Valuation - Increased Demand Driving Increase in Value

Source: Infratil Limited



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Napier Port Holdings Limited (NZX: NPH) 2021 Earnings Guidance Update
Comvita Limited (NZX: CVT) Full Year Guidance Update
Scott Technology Limited (NZX: SCT) Meat Industry Contract Win
PaySauce Limited (NZX: PYS) Quarterly Market Update
NZ Windfarms Limited (NZX: NWF) Agrees a New VVFPA for Q1 2022 to Q3 2022
Harmoney Corp Limited (NZX: HMY) 3Q21 Trading Update
Pacific Edge Limited (NZX: PEB) United Healthcare Issues Positive Coverage Cxbladder
Scott Technology Limited (NZX: SCT) 2021 Half Year Announcement
NZX Limited (NZX: NZX) Appoints Specialist Global Expert to Tech Committee
AFT Pharmaceuticals Limited (NZX: AFT) Secures New Partners in Poland and Greece